FDA Clearance Tracker · P230040-S001
Cordella Pulmonary Artery Sensor System (CorPASS)
Last checked: Nov 20, 2026Latest source record: Oct 4, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 4, 2024
Approved
Time to decision
77 days
Received Jul 19, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230040-S001
- Device name
- Cordella Pulmonary Artery Sensor System (CorPASS)
- Applicant
- Endotronix, Inc.
- Applicant location
- Naperville, IL
- Received
- Jul 19, 2024
- Decided
- Oct 4, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P230040
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230040
Source documents
Other decisions for Endotronix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230040 · Decided Jun 20, 2024 · 190 days after receipt
Device type: System, hemodynamic, implantable (MOM) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.